Puma Biotechnology Stock (NASDAQ:PBYI), Quotes and News Summary - Benzinga
HCW starts Puma Biotechnology at buy; PT $15 - BioTuesdays
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer - Puma Biotechnology (NASDAQ:PBYI) - Benzinga
PUMA BIOTECHNOLOGY, INC. General Corporate Statement (Form8) - Puma Biotechnology (NASDAQ:PBYI) - Benzinga
Puma Biotechnology, Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
Puma Biotechnology Seen as Takeover Target After Strong Cancer Drug Data - TheStreet
PUMA BIOTECHNOLOGY, INC. FORM 8-K/A - Shareholder.com
Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals | Seeking Alpha
Puma Biotechnology: That's Some Target Increase!!! | Barron's
Puma Biotechnology: Too Little, Too Late, Too Much Of A Bad Side Effect (NASDAQ:PBYI) | Seeking Alpha
PUMA Biotechnology, Inc. Form S-1
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Is Puma Biotechnology a Buy? | The Motley Fool
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
printmgr file
pbyi-def14a_20210615.htm
Articles with Puma Biotechnology
Does Puma's quick Nerlynx launch play into its buyout prospects? | Fierce Pharma
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
PBYI Stock Forecast, Price & News (Puma Biotechnology)
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Here's Why Puma Biotechnology Tumbled Today | The Motley Fool
Puma Biotechnology
PBYI STOCK NEWS | PUMA BIOTECHNOLOGY INC BIG TARGET - YouTube
